215 related articles for article (PubMed ID: 20480411)
1. WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC).
Baykara O; Demirkaya A; Kaynak K; Tanju S; Toker A; Buyru N
Tumour Biol; 2010 Aug; 31(4):315-20. PubMed ID: 20480411
[TBL] [Abstract][Full Text] [Related]
2. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of WWOX in the development of esophageal squamous cell carcinoma.
Guo W; Wang G; Dong Y; Guo Y; Kuang G; Dong Z
Mol Carcinog; 2013 Apr; 52(4):265-74. PubMed ID: 22213016
[TBL] [Abstract][Full Text] [Related]
4. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoking extract causes hypermethylation and inactivation of WWOX gene in T-24 human bladder cancer cells.
Yang W; Cui S; Ma J; Lu Q; Kong C; Liu T; Sun Z
Neoplasma; 2012; 59(2):216-23. PubMed ID: 22248280
[TBL] [Abstract][Full Text] [Related]
9. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV
Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic and genetic alterations affect the WWOX gene in head and neck squamous cell carcinoma.
Ekizoglu S; Bulut P; Karaman E; Kilic E; Buyru N
PLoS One; 2015; 10(1):e0115353. PubMed ID: 25612104
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma.
Yang Z; Lan H; Chen X; Li P; Li S; Mo W; Tang A
Neoplasma; 2014; 61(2):170-6. PubMed ID: 24299313
[TBL] [Abstract][Full Text] [Related]
12. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.
Kuroki T; Yendamuri S; Trapasso F; Matsuyama A; Aqeilan RI; Alder H; Rattan S; Cesari R; Nolli ML; Williams NN; Mori M; Kanematsu T; Croce CM
Clin Cancer Res; 2004 Apr; 10(7):2459-65. PubMed ID: 15073125
[TBL] [Abstract][Full Text] [Related]
14. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
[TBL] [Abstract][Full Text] [Related]
15. Loss of WWOX expression in gastric carcinoma.
Aqeilan RI; Kuroki T; Pekarsky Y; Albagha O; Trapasso F; Baffa R; Huebner K; Edmonds P; Croce CM
Clin Cancer Res; 2004 May; 10(9):3053-8. PubMed ID: 15131042
[TBL] [Abstract][Full Text] [Related]
16. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.
Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G
Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129
[TBL] [Abstract][Full Text] [Related]
17. The polymorphisms and haplotypes of WWOX gene are associated with the risk of lung cancer in southern and eastern Chinese populations.
Huang D; Qiu F; Yang L; Li Y; Cheng M; Wang H; Ma G; Wang Y; Hu M; Ji W; Zhou Y; Lu J
Mol Carcinog; 2013 Nov; 52 Suppl 1():E19-27. PubMed ID: 22693020
[TBL] [Abstract][Full Text] [Related]
18. Deletion and mutation of WWOX exons 6-8 in human non-small cell lung cancer.
Zhou Y; Xu Y; Zhang Z
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):162-5. PubMed ID: 16116962
[TBL] [Abstract][Full Text] [Related]
19. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
[TBL] [Abstract][Full Text] [Related]
20. Relationship between epidermal growth factor receptor gene mutations and clinicopathological features in patients with non-small cell lung cancer in western Turkey.
Unal OU; Oztop I; Calibasi G; Baskin Y; Koca D; Demir N; Akman T; Ellidokuz H; Yilmaz AU
Asian Pac J Cancer Prev; 2013; 14(6):3705-9. PubMed ID: 23886169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
